ti

aj

sn2

atJ

ORGD

vivmwartn

SF

TNB

TIS

stnburtBcemd

TDDC

Symposia

1

Milan SB, Zardeneta G, Schmitz JP: Oxidative stress and degenerativeemporomandibular joint disease: A proposed hypothesis. J Oral Max-llofac Surg 56: 214-223, 1998

Nitzan DW, Etsion I: Adhesive force: the underlying cause of the discnchorage to the fossa and /or eminence in the temporomandibularoint–A new Concept. Int J. Oral Maxillofac Surg 31:94-99, 2002

Murakami KI, Tsuboi Y, Bessho K, et al: Outcome of arthroscopicurgery to the temporomandibular joint correlates with stage of inter-al derangement: Five-year follow up study. Br J Oral Maxillofac Surg6:30, 1998Israel HA, Diamond BE, Saed-Nejad F, et al: Correlation between

rthroscopic diagnosis of osteoarthritis and synovitis of the humanemporomandibular joint and keratin sulfate levels in the synovial fluid.Oral Maxillofac Surg 55:210, 1997

pen Joint Surgery and Total Jointeplacementerald I. Baker, DDS, MS, Toronto, Ontario, Canada

avid J. Psutka, DDS, Mississauga, Ontario, Canada

riday, October 16, 2009, 3:30 pm–5:30 pm

anada

lacsitcpd

1

3

TET

TED

a

6

The majority of TMJ disorders are manageable witharious medical, dental and physiotherapeutic modal-ties. A variety of TMJ disorders warrant surgical inter-ention, with minimally invasive protocols being theost common initial strategy. There still remains aell defined group of patients requiring open surgery

nd within this subset, there are those who requireesection of severely diseased and hopelessly damagedissue with reconstruction using a variety of autoge-ous or alloplastic materials. This lecture will present:- Current indications for open TMJ joint surgery.- Discussion of outcomes for various forms of open

surgery.- Indications for autogenous vs alloplastic TMJ recon-

struction.- Review of our 15-year experience with three alloplas-

tic total joint prostheses used to replace 620 TM Joints.- Our protocol for prescribing stock vs custom total

TMJ prosthesis.

YMPOSIUM ON MENTORING AND NETWORKING IN ACADEMICS

he Role of a Mentor: Establishing andurturing Research Collaborations

ruce Baum, DMD, PhD, Bethesda, MD

No abstract provided

he Role of a Mentor and themportance of Networkingtephen E. Feinberg, DDS, MS, PhD, Ann Arbor, MI

It is critical that all young clinician-scientists under-tand that mentoring and networking are valuableools for their career. These contacts can provide aew clinician-scientist advice and assistance that wille beneficial for many years. A scientist must alsonderstand that both being a mentee and networkingequire preparation and effort. This investment ofime should be seen as an investment in one’s career.y taking advantage of mentoring and networkingontacts, a clinician-scientist’s career can be greatlynhanced, leading to new research opportunities andore rapid career advancement. These issues will be

iscussed in this presentation.

he Role of a Mentor and theevelopment of an Academic Careeravid S. Precious, DDS, MSc, Halifax, Nova Scotia,

It is generally agreed that most people achieve higherevels of professional success if they have a mentor to directnd advise them. Mentoring is central to academic medi-ine and dentistry but clinical duties, administrative respon-ibilities, research and clinical care intrude in the mentor-ng process. Moreover the evidence to support the notionhat mentoring is an important part of the academic healthare experience is not strong. This paper will discuss therevalence of mentorship and its relationship to careerevelopment in oral and maxillofacial surgery.

References

Roche G R. Much ado about mentors. Harvard Bus Rev 1979: 1,4-28Donovan J. Mentoring satisfied residents. Arch Dermatol 2009: 145,

35-336

he Mentee’s Perspective: Myxperiencesara L. Aghaloo, DDS, MD, PhD, Los Angeles, CA

No abstract provided

he Mentee’s Perspective: Myxperiencesavid L. Basi, DMD, PhD, Minneapolis, MN

Clinician, educator and scientist, the core missions of

n academic surgeon, are increasingly difficult to suc-

AAOMS • 2009

cfsptlttbmtptP

MsmTmwppsamdr

SDS

ILL

AOJ

AF

FE

edcchcnttc

Symposia

A

essfully achieve. Many surgeons have made a careerocusing on just one of the core academic duties. Toucceed at all three is increasingly unusual due to variousersonal and professional factors. Mentorship is essentialo help guide young faculty to become a successfulong-term academician. My career in research was nur-ured during my undergraduate dental school training athe University of Pittsburgh. I had an interest in science,ut it was my mentor Dr Suda Agarwal who encouragede to pursue this as part of my career. Beyond teaching

he fundamentals of science, she made sure I wasresenting at AADR/IADR. This led to my introductiono Dr Mark Herzberg, who subsequently became my

hD advisor as I was accepted into the University of a

aturday, October 17, 2009, 7:30 am–9:30 am

onsequences, including death of the patient. Such di-

ac

gedotcpfimapptahpbte

AOMS • 2009

innesota’s Dental Scientist Program. While I hadtrong academic mentorship during my PhD program,y interest in surgery was developed less formally.he surgeons I encountered who impacted me theost led by example. Dr Michael J. Buckley not onlyas a skilled oral and maxillofacial surgeon but alsoerformed basic science research. He encouraged myursuit in an academic career of both surgery andcience. Dr James Q. Swift honed my surgical skillsnd has provided me with invaluable guidance duringy early years as an academic surgeon. As I further

evelop in my career I understand the challenges andewards of being a mentor to the next generation of

cademic surgeons.

YMPOSIUM ON INTRAOPERATIVE COMPLICATIONS INENTOALVEOLAR SURGERY

ntroduction With Update on State ofitigation/Defenseewis N. Estabrooks, DMD, MS, Saint Petersburg, FL

No abstract provided

lveolar Osteitis That Progresses to ansteomyelitis

ohn F. Caccamese, DMD, MD, Baltimore, MD

No abstract provided

ntibiotic Caserank Hohn, DDS, Saskatoon, Saskatchewan, Canada

No abstract provided

ailure to Diagnose Cancerric R. Carlson, DMD, MD, Knoxville, TN

It has often been said that there is no lethal diseaseasier to treat than an oral cancer smaller than 1 cm iniameter. While the genetics of a cancer of the oralavity, not its size, represent the main determinant of aancer’s biologic behavior, certainly some small cancersave favorable genetics that may permit cure of thatancer. No doubt, prophylactic management of occulteck disease lends itself to a possible cure depending onhe number and character of cervical metastases. Failureo diagnose a cancer of any size can have devastating

gnostic failures can be classified into the followingategories:

1. Failure to biopsy a clinically apparent cancerwhen it is not recognized as such.

2. Submission of a non-representative biopsy of acancer (eg too small, incorporation of non-diag-nostic necrotic material, etc).

3. Failure to re-biopsy a lesion whose original bi-opsy identified a potentially pre-malignant orequivocal lesion where the patient’s symptomspersist or worsen.

4. Failure to provide accurate histopathologic diag-nosis of a lesion known to progress from a pre-malignant to a malignant state.

Oral mucosal dysplastic disease may demonstrate pro-ression from pre-malignant disease to malignant dis-ase. Traumatic and other inflammatory oral mucosaliseases may also progress to malignancy. Perhaps onef the most enigmatic oral lesions is lichen planus, par-icularly with regard to its malignant potential. Somelinicians and pathologists are convinced that lichenlanus is a potentially precancerous lesion, and somermly believe that this lesion is distinctly benign. Whenalignant transformation occurs it is most commonly

ssociated with the atrophic and erosive forms of lichenlanus. A general consensus exists that describes atro-hic and erosive lichen planus at risk for malignantransformation, or with malignant potential, rather thans a precancerous lesion. As such, when encountering suchistologic and/or clinical diagnoses, the surgeon shouldrovide clinical surveillance accordingly. After a biopsy haseen performed, and a microscopic diagnosis rendered,he surgeon must continue to provide periodic clinical

xaminations and determine the utility of future re-biopsy.

17